Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
At NINGBO INNO PHARMCHEM CO.,LTD., we are committed to supplying Active Pharmaceutical Ingredients (APIs) that provide comprehensive health benefits. Canagliflozin Hemihydrate, a prominent SGLT2 inhibitor, exemplifies this commitment by offering not only superior glycemic control but also significant advantages in cardiovascular risk reduction for individuals with type 2 diabetes.
Type 2 diabetes is frequently associated with an increased risk of cardiovascular diseases, including heart attacks, strokes, and heart failure. The therapeutic profile of Canagliflozin Hemihydrate addresses this challenge through its unique pharmacological properties. While its primary action is to lower blood glucose by increasing urinary glucose excretion, this process initiates a cascade of beneficial effects that extend to the cardiovascular system. Studies have consistently shown that Canagliflozin Hemihydrate can lead to a notable reduction in major adverse cardiovascular events (MACE) in patients with type 2 diabetes, particularly those with established cardiovascular disease or multiple risk factors.
The cardiovascular benefits of Canagliflozin Hemihydrate are thought to be multifactorial. These may include improvements in blood pressure, reductions in body weight, favorable effects on lipid profiles (such as increased HDL cholesterol and decreased LDL cholesterol), and potentially direct protective effects on the heart muscle and vasculature. The SGLT2 inhibitor class, to which Canagliflozin Hemihydrate belongs, has been recognized for its role in mitigating heart failure hospitalizations and reducing cardiovascular mortality. This makes it a crucial component in the treatment strategy for patients requiring cardiovascular risk reduction in diabetes.
For pharmaceutical companies looking to develop treatments for type 2 diabetes with a focus on cardiovascular health, sourcing high-quality Canagliflozin Hemihydrate is a strategic move. NINGBO INNO PHARMCHEM CO.,LTD. provides this API with the highest standards of purity and regulatory compliance, ensuring that formulators can confidently integrate it into their products. By understanding the crucial role of APIs in achieving these dual benefits, companies can effectively cater to the complex needs of diabetic patients. The pursuit of innovations in glycemic control that also addresses cardiovascular health is a key objective in modern medicine.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
